Bladder Cancer Clinical Trial

Urine-based Molecular Testing vs Cystoscopy for Surveillance of Nonmuscle Invasive Bladder Cancer (NMIBC)

Summary

The purpose of this study is to evaluate patient-reported preference for CxBladder Monitor compared to cystoscopy for patients on surveillance for Nonmuscle Invasive Bladder Cancer (NMIBC).

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Male or female with a history of histologically confirmed stage 0 (Ta and/or CIS) nonmuscle invasive bladder cancer who have at least 9 months of disease-free survival from last recurrence.
Able to provide urine for testing and comply with study protocol.
Have an email address and be willing to complete surveys online.

Exclusion Criteria:

History of non-urothelial bladder cancer (primary squamous, adenocarcinoma, and small cell carcinoma)
Patients with predominant (>50%) variant histology
Patients with a history of upper tract and/or urethral cancer
Patients with a history of T1 NMIBC
Women who are pregnant

Study is for people with:

Bladder Cancer

Estimated Enrollment:

107

Study ID:

NCT06126796

Recruitment Status:

Recruiting

Sponsor:

Mayo Clinic

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 3 Locations for this study

See Locations Near You

Mayo Clinic in Arizona
Scottsdale Arizona, 85259, United States More Info
Clinical Trials Referral Office
Contact
855-776-0015
[email protected]
Mark D. Tyson, M.D., M.P.H.
Principal Investigator
Mayo Clinic in Florida
Jacksonville Florida, 32224, United States More Info
Clinical Trials Referral Office
Contact
855-776-0015
[email protected]
Mark D. Tyson, M.D., M.P.H.
Principal Investigator
Mayo Clinic in Rochester
Rochester Minnesota, 55905, United States More Info
Clinical Trials Referral Office
Contact
855-776-0015
[email protected]
Mark D. Tyson, M.D., M.P.H.
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Bladder Cancer

Estimated Enrollment:

107

Study ID:

NCT06126796

Recruitment Status:

Recruiting

Sponsor:


Mayo Clinic

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.